HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear?
Ferretti
Gianluigi
G
Di Cosimo
Serena
S
Giannarelli
Diana
D
Carlini
Paolo
P
Papaldo
Paola
P
Alimonti
Andrea
A
Fabi
Alessandra
A
Mandalà
Mario
M
Milella
Michele
M
Ruggeri
Enzo Maria
EM
Cognetti
Francesco
F
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D017024:Chemotherapy, Adjuvant; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D017697:Premenopause; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D013629:Tamoxifen / Q000627:therapeutic use*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D013629:Tamoxifen